Evidence map›Paper›PMID 19966290›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Role of the translocation partner in protection against AID-dependent chromosomal translocations.

Mila Jankovic, Davide F Robbiani, Yair Dorsett, Thomas Eisenreich, Yang Xu, Alexander Tarakhovsky, Andre Nussenzweig, Michel C Nussenzweig

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Mila JankovicLaboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.
Davide F Robbiani
Yair Dorsett
Thomas Eisenreich
Yang Xu
Alexander Tarakhovsky
Andre Nussenzweig
Michel C Nussenzweig
Center of Molecular Immunology (Cuba) · CURockefeller University · USHoward Hughes Medical Institute · USNational Institutes of Health · USUniversity of California, San Diego · US

Funding

DNA RepairZIABC010283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Relationship between DNA damage detection and signalingZIABC010959 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Class Switch Recombination in B LymphocytesR37AI037526 · NIAID · ROCKEFELLER UNIVERSITY · PI NUSSENZWEIG, MICHEL C · 2014 to 2023
$5.4M
SIGNALLING PATHWAYS IN AUTOIMMUNITYR01AI037526 · NIAID · ROCKEFELLER UNIVERSITY · PI NUSSENZWEIG, MICHEL C · 1994 to 2012
$5.0M
Howard Hughes Medical InstituteIntramural NIH HHSNIAID NIH HHS AI037526NIAID NIH HHS R01 AI037526NIAID NIH HHS R37 AI037526
6 · The paper itself

Abstract

Chromosome translocations between Ig (Ig) and non-Ig genes are frequently associated with B-cell lymphomas in humans and mice. The best characterized of these is c-myc/IgH translocation, which is associated with Burkitt's lymphoma. These translocations are caused by activation-induced cytidine deaminase (AID), which produces double-strand DNA breaks in both genes. c-myc/IgH translocations are rare events, in part because ATM, p53, and p19 actively suppress them. To further define the mechanism of protection against the accumulation of cells that bear c-myc/IgH translocation, we assayed B cells from mice that carry mutations in cell-cycle and apoptosis regulator proteins that act downstream of p53. We find that PUMA, Bim, and PKCdelta are required for protection against c-myc/IgH translocation, whereas Bcl-XL and BAFF enhance c-myc/IgH translocation. Whether these effects are general or specific to c-myc/IgH translocation and whether AID produces dsDNA breaks in genes other than c-myc and Ig is not known. To examine these questions, we developed an assay for translocation between IgH and Igbeta, both of which are somatically mutated by AID. Igbeta/IgH, like c-myc/IgH translocations, are AID-dependent, and AID is responsible for lesions on IgH and the non-IgH translocation partners. However, ATM, p53, and p19 do not protect against Igbeta/IgH translocations. Instead, B cells are protected against Igbeta/IgH translocations by a BAFF- and PKCdelta-dependent pathway. We conclude that AID-induced double-strand breaks in non-Ig genes other than c-myc lead to their translocation, and that at least two nonoverlapping pathways protect against translocations in primary B cells.

Indexed as

Translocation, GeneticAICDA (Activation-Induced Cytidine Deaminase)AnimalsApoptosis Regulatory ProteinsAtaxia Telangiectasia Mutated ProteinsBcl-2-Like Protein 11B-LymphocytesCell Cycle ProteinsCells, CulturedCell Transformation, NeoplasticCyclin-Dependent Kinase Inhibitor p19Cytidine DeaminaseDNA-Binding ProteinsGenes, ImmunoglobulinHumansMembrane ProteinsAICDA (Activation-Induced Cytidine Deaminase)Apoptosis Regulatory ProteinsAtaxia Telangiectasia Mutated ProteinsATM protein, humanAtm protein, mouseBCL2L11 protein, humanBcl2l11 protein, mouseBcl-2-Like Protein 11Cell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p19Cytidine DeaminaseDNA-Binding ProteinsMembrane ProteinsMyc protein, mouseProtein Kinase C-deltaProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-mycPUMA protein, mouseTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID19966290
PMCPMC2806756
OpenAlexW1965968822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.